Canada Gears Up For Expected Rise In Biosimilar Filings
Executive Summary
Efforts are under way in Canada to strengthen the regulator’s ability to evaluate the growing number of biosimilar filings, and to increase confidence in the biosimilar regulatory framework through targeted outreach and education activities.